Detail

Study ID: NRN MoCHA Trial

Title:

Randomized Controlled Trial of Home Therapy with Caffeine Citrate in Moderately Preterm Infants with Apnea of Prematurity. Short Title: Moderately Preterm Infants with Caffeine at Home for Apnea (MoCHA) Trial

Description:
Title: Randomized Controlled Trial of Home Therapy with Caffeine Citrate in Moderately Preterm Infants with Apnea of Prematurity (MoCHA) Description: This is a research study looking at the use of caffeine in the hospital and after discharge. Caffeine is a medicine commonly used to treat apnea of prematurity. Babies who were born between 29 and 33 weeks gestational age and have a history of apnea will be invited to be part of this study.
Location:
Sioux Falls Region
Principal Investigator:
Suzanne Reuter
Disease:
Lung
Stage:
Unknown
Status:
Active - Open to Accrual